Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

Suppr

超能文献

作者信息

Chabner B A, Fojo A

机构信息

Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.

出版信息

J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910.

DOI:10.1093/jnci/81.12.910

PMID:2567356

Abstract

摘要

相似文献

Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910.

Multidrug resistance: molecular biology and clinical relevance.

J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.

Multidrug resistance due to P-glycoprotein.

Hosp Pract (Off Ed). 1990 Apr 15;25(4):67-72, 74, 77. doi: 10.1080/21548331.1990.11703935.

Multidrug resistance in human cancer.

Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.

Multidrug resistance in leukemia.

Cancer Treat Res. 1993;64:269-93. doi: 10.1007/978-1-4615-3086-2_13.

Drug resistance and cancer.

Adv Exp Med Biol. 1993;330:287-305. doi: 10.1007/978-1-4615-2926-2_20.

Multidrug resistance: a novel class of membrane-associated transport proteins is identified.

Cancer Invest. 1991;9(5):563-9. doi: 10.3109/07357909109018954.

Clinical implications of multidrug resistance to chemotherapy.

Cancer Treat Res. 1991;57:171-86. doi: 10.1007/978-1-4615-3872-1_8.

[Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].

Med Clin (Barc). 1994 Apr 9;102(13):506-15.

The role of P-glycoprotein in drug-resistant hematologic malignancies.

Cancer Treat Res. 1991;57:187-208. doi: 10.1007/978-1-4615-3872-1_9.

引用本文的文献

Antiproliferative Activity of : Overcoming Chemoresistance.

Comb Chem High Throughput Screen. 2025;28(7):1264-1275. doi: 10.2174/0113862073322175240823104921.

Silencing of the ARK5 gene reverses the drug resistance of multidrug-resistant SGC7901/DDP gastric cancer cells.

PeerJ. 2020 Aug 7;8:e9560. doi: 10.7717/peerj.9560. eCollection 2020.

Investigation of multidrug resistance in cultured human renal cell carcinoma cells by 31P-NMR spectroscopy and treatment survival assays.

MAGMA. 2005 Jul;18(3):144-61. doi: 10.1007/s10334-005-0107-7. Epub 2005 Jun 23.

Non-Hodgkin's lymphoma in the elderly: a guide to drug treatment.

Drugs Aging. 1999 Jun;14(6):447-57. doi: 10.2165/00002512-199914060-00005.

Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.

Cancer Metastasis Rev. 1995 Dec;14(4):323-38. doi: 10.1007/BF00690601.

Targeting chemosensitizing doses of toremifene based on protein binding.

Cancer Chemother Pharmacol. 1993;31(5):412-4. doi: 10.1007/BF00686157.

Etoposide-resistant human colon and lung adenocarcinoma cell lines exhibit sensitivity to homoharringtonine.

Cancer Chemother Pharmacol. 1993;33(2):149-53. doi: 10.1007/BF00685333.

Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.

Cancer Chemother Pharmacol. 1993;32(2):116-22. doi: 10.1007/BF00685613.

Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.

Br J Cancer. 1993 Mar;67(3):471-9. doi: 10.1038/bjc.1993.89.

Regulation of initial vinblastine influx by P-glycoprotein.

Br J Cancer. 1993 Jan;67(1):30-6. doi: 10.1038/bjc.1993.6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验